Site search

EBShield Research study

This study is an international clinical trial for people with Epidermolysis Bullosa Simplex (EBS).

TRAILBLAZER-ALZ 5 Research study

This study is testing a potential new treatment called donanemab (also known as LY3002813) for people with early Alzheimer’s Disease.

Can fenofibrate protect against eye damage in early retinopathy for adults with Type 1 diabetes Research study

A clinical trial to assess whether fenofibrate can protect against eye damage in early retinopathy in adults with type 1 diabetes

Falls and Balance Clinic RMH Service

We provide multidisciplinary assessment and management planning for patients who have had falls and who have mobility and balance problems.

A new potential therapy for depression Research study

This large international trial will examine the efficacy and safety of a new potential therapy for treatment-resistant depression.

The Kite trial Research study

The Kite trial is investigating whether low-dose ketamine is effective in reducing depressive symptoms in adults with bipolar depression.

Can over-the-counter supplements reduce diabetes-related painful peripheral neuropathy? Research study

The Mito-PPND Study  seeks to assess the safety and effectiveness of a combination of over-the-counter supplements for reducing painful peripheral neuropathy

Donanemab in early symptomatic Alzheimer’s disease Research study

A study to determine the safety and efficacy of a drug called donanemab in treating or delaying the progression of Alzheimer’s dementia.

The AUTUMN study: researching a new medicine for membranous nephropathy Research study

This study is testing a new medicine called ALXN1920 for people with a kidney disease called membranous nephropathy.

BI 456906 for non-alcoholic steatohepatitis (NASH) and liver fibrosis Research study

A study to test whether different doses of BI 456906 are effective in people with a liver disease called non-alcoholic steatohepatitis (NASH) and liver fibrosis.

Experimental treatment for Parkinson’s disease Research study

This is a study of an experimental treatment (referred to as “study drug”) called CVL-751 as a possible treatment for Parkinson’s disease.

Metformin and atorvastatin for adults with depression Research study

The Hearts and Minds clinical trial is aiming to determine whether metformin or atorvastatin help to reduce symptoms of major depression and improve quality of life.

Denosumab as a prevention for breast cancer in women with a BRCA1 mutation Research study

This research is to find out whether the study medication, denosumab, can help prevent breast cancer in women with a BRCA1 mutation.

Remibrutinib for chronic spontaneous urticaria Research study

A clinical trial to assess a new drug for chronic spontaneous urticaria (CSU) not controlled with antihistamine medication or omalizumab (Xolair®) in the past.

Trial to assess a new tablet for plaque psoriasis Research study

Plaque psoriasis is an autoimmune condition characterised by dry, itchy and scaly skin patches. This trial investigates whether people with plaque psoriasis may be able to take an oral treatment to improve the condition.

Virtual Ward RMH Service

The Virtual Ward allows eligible patients to receive hospital-level treatment from home. Virtual Ward patients attend appointments with their care team via Telehealth video call, or receive at-home visits when needed.

Assessing a new tablet for plaque psoriasis Research study

Understanding the effect of medication on the body's inflammatory response may lead to new treatments for autoimmune conditions, including psoriasis.

WVE-003 in patients with Huntington’s disease Research study

A multicentre, randomised, double-blind, placebo-controlled, phase 1b/2a study of WVE-003 in patients with Huntington’s disease.

Abatacept combined with nasal insulin to preserve beta-cell function in recently diagnosed type 1 diabetes Research study

Preserving pancreas function can make glucose control easier and reduce the need to use injected insulin

The RMH patient, Elias Frantzeskos celebrates DonateLife Week News article

Elias Frantzeskos came into the world 7 weeks early with poor function of his kidney.